Johnson & Johnson

Johnson & Johnson
Company typePublic
Traded as
  • NYSE: JNJ
  • DJIA component
  • S&P 100 component
  • S&P 500 component
ISINUS4781601046
Industry
FoundedJanuary 1886 (1886-01) in New Brunswick, New Jersey, U.S.
Founders
  • Robert Wood Johnson I
  • James Wood Johnson
  • Edward Mead Johnson
HeadquartersJohnson and Johnson Plaza,
New Brunswick, New Jersey
,
U.S.
40°29′55″N 74°26′37″W / 40.49861°N 74.44361°W / 40.49861; -74.44361
Area served
Worldwide
Key people
  • Joaquin Duato (chairman & CEO)
ProductsList of Johnson & Johnson products and services
Revenue US$88.82 billion (2024)
Operating income
US$20.80 billion (2024)
Net income
US$14.07 billion (2024)
Total assets US$180.1 billion (2024)
Total equity US$71.49 billion (2024)
Number of employees
138,100 (2024)
Subsidiaries
  • Johnson & Johnson Pharmaceutical Research and Development
    • Actelion Pharmaceuticals
    • Cilag
    • Janssen Biologics
    • Janssen Global Services
    • Janssen Therapeutics
    • Janssen Vaccines & Prevention
    • Momenta Pharmaceuticals
  • Johnson & Johnson MedTech
    • Abiomed
    • Acclarent
    • Biosense Webster
    • Cerenovus
    • DePuy Synthes
    • Ethicon
    • Johnson & Johnson Vision
    • Mentor
    • Synthes
    • V-Wave
    • Shockwave Medical
  • Johnson & Johnson Services
Websitejnj.com
Footnotes / references
[1]

Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 42 on the 2024 Fortune 500 list of the largest United States corporations.[2] In 2024, the company was ranked 45th in the Forbes Global 2000.[3] Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.

Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split-off its consumer healthcare business segment into a new publicly traded company, Kenvue. The company is exclusively focused on developing and producing pharmaceutical prescription drugs and medical device technologies.

Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.[4]

  1. ^ "Johnson and Johnson 2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. February 13, 2025.
  2. ^ "Johnson & Johnson". Fortune. Retrieved March 26, 2025.
  3. ^ SCHIFRIN", "ANDREA MURPHY"," MATT. "Forbes 2024 Global 2000 List - The World's Largest Companies Ranked". Forbes. Retrieved March 26, 2025.{{cite web}}: CS1 maint: multiple names: authors list (link)
  4. ^ "Looking to Bet On Perfect AAA Credit Ratings? Play These ETFs". Yahoo Finance. August 3, 2023. Retrieved August 24, 2023.